The predictive value indicators of first trimester biochemical screening in assessing unfavorable factors of pregnancy course in women with HIV as well as hepatitis B and C
Abstract
Aim: to find out the predictive value of blood serum biochemical parameters PAPP-A (pregnancy-associated plasma protein A) and β-hCG (beta subunit of human chorionic gonadotropin) in the assessment of unfavorable pregnancy outcomes in women infected by human immunodeficiency virus (HIV) as well as viral hepatitis B (HBV) and C (HCV).
Materials and Methods. A retrospective study of the medical records from 52 women was carried out, including 19 HIV-infected women, 9 women with monoinfection HBV or HCV, 11 pregnant women who were co-infected (HIV/HBV or HIV/HCV) and 13 uninfected women. PAPP-A and β-hCG levels, expressed as MoM (multiple of median), were evaluated in all women.
Results. Our study revealed that only PAPP-A was prognostically significant for developing chronic placental insufficiency in women with HIV infection and co-infection of HIV together hepatitis B and C. None of the parameters examined were significant in women with HBV or HCV monoinfection. PAPP-A and β-hCG in pregnant women without infections were effective in predicting development of chronic placental insufficiency.
Conclusion. PAPP-A can be used as a diagnostic parameter of developing chronic placental insufficiency in pregnant women with monoinfection HIV and co-infection with HIV/HBV or HIV/HCV.
About the Authors
S. Yu. Pseush
Kuban State University
Russian Federation
Russian Federation
Saida Yu. Pseush – Bachelor, Faculty of Biology, Department of Genetics, Microbiology and Biochemistry
149 Stavropolskaya Str., Krasnodar 350040
L. V. Zozulya
Kuban State University
Russian Federation
Russian Federation
Lada V. Zozulya – MD, PhD (Biology), Associate Professor, Department of Genetics, Microbiology and Biochemistry
149 Stavropolskaya Str., Krasnodar 350040
L. L. Mikhaleva
Perinatal Center «Children's Regional Clinical Hospital», Ministry of Health of Krasnodar Region
Russian Federation
Russian Federation
Lada L. Mikhaleva – MD, Biologist, Clinical Diagnostic Laboratory
1 Pobedy Square, Krasnodar 350007
References
1. HIV/AIDS. World Health Organization, 2021. Available at: https://www.who.int/news-room/fact-sheets/detail/hiv-aids. [Accessed: 15.07.2021].
2. Ladnaya N.N., Pokrovsky V.V., Dementyeva L.A., Sokolova E.V. The epidemic situation of HIV infection in the Russian Federation in 2019. [Epidemicheskaya situaciya po VICh-infekcii v Rossijskoj Federacii v 2019 g]. Epidemiologiya i infekcionnye bolezni. Aktual'nye voprosy. 2020;10(3):17–26. (In Russ.).
3. Hepatitis C and HIV infection: management tactics for patients with co-infection. Clinical protocol for the WHO European Region. [Gepatit S i VICh-infekciya: taktika vedeniya pacientov s sochetannoj infekciej. Klinicheskij protokol dlya Evropejskogo regiona VOZ]. Vsemirnaya organizaciya zdravoohraneniya, 2006. 53 p. (In Russ.). Available at: https://www.euro.who.int/__data/assets/pdf_file/0010/78148/HEP_C_rus.pdf. [Accessed: 15.07.2021].
4. Hepatitis B and HIV infection: management tactics for patients with co-infection. Clinical protocol for the WHO European Region. [Gepatit B i VICh-infekciya: taktika vedeniya pacientov s sochetannoj infekciej. Klinicheskij protokol dlya Evropejskogo regiona VOZ]. Vsemirnaya organizaciya zdravoohraneniya, 2006. 31 p. (In Russ.). Available at: https://www.euro.who.int/__data/assets/pdf_file/0007/91942/HEP_B_rus.pdf. [Accessed: 15.07.2021].
5. Bogomolova I.V. Some aspects of chronic placental dysfunction and perinatal outcomes in HIV-infected pregnant women. [Nekotorye aspekty hronicheskoj fetoplacentarnoj disfunkcii i perinatal'nye iskhody u VICh-inficirovannyh beremennyh]. Zhurnal akusherstva i zhenskih boleznej. 2017;66(S):102–3. (In Russ.).
6. Mohamad J.R., Masihi S., Barati M. et al. Value of pregnancy-associated plasma protein-A for predicting adverse pregnancy outcome. Arch Iran Med. 2019;22(10):584–7. PMID: 31679360.
7. Zamanskaya T.A., Evseeva Z.P., Evseev A.V. Biochemical screening in the first trimester on predicting the complications of pregnancy. [Biohimicheskij skrining v I trimestre pri prognozirovanii oslozhnenij beremennosti]. Rossijskij vestnik akushera-ginekologa. 2008;8(3):71–3. (In Russ.).
8. Kudryavtseva E.V., Kovalev V.V., Baranov I.I. et al. Correlation of prenatal screening indicators of the I trimester with the risk of pregnancy complications. [Vzaimosvyaz' pokazatelej prenatal'nogo skrininga I trimestra s riskom oslozhnenij beremennosti]. Akusherstvo i ginekologiya. Novosti. Mneniya. Obuchenie. 2020;8(1):38–46. (In Russ.). https://doi.org/10.24411/2303-9698-2020-11005.
9. Kasparova A.E., Belotserkovtseva L.D., Kovalenko L.V., Sus L.A. Screenings in early pregnancy: is it possible to predict the formation of cardio-placental insufficiency in preeclampsia. [Skriningi v rannie sroki beremennosti: vozmozhen li prognoz formirovaniya kardio-placentarnoj nedostatochnosti pri preeklampsii]. Vestnik RUDN. Seriya: Medicina. 2011;(S5):123–32. (In Russ.).
10. Kystaubayeva A.S., Tanysheva G.A., Sharipova M.G. et al. The influence of pregnancy-associated plasma proteinA (PAPP-A) on intrauterine growth restriction. [Vliyanie urovnya soderzhaniya associirovannogo s beremennost'yu plazmennogo belka-A (RARR-A) na razvitie narushenij rosta ploda]. Nauka i zdravoohranenie. 2017;(5):55–66. (In Russ.).
11. Nikolaeva Yu.A., Kascheeva T.K., Baranov V.S. The role of biochemical maternal serum markers in prognosis of obstetrical complications. [Znachenie markernyh syvorotochnyh belkov dlya prognoza patologii techeniya beremennosti i sostoyaniya novorozhdennogo]. Zhurnal akusherstva i zhenskih boleznej. 2012;61(3):94–103. (In Russ.).
12. Tsibizova V.I., Govorov I.E., Pervunina T.M. et al. First trimester prenatal screening in multiple pregnancies. Part II: serum proteins PAPP-A and β-hCG as markers of adverse pregnancy outcomes. Obstetrics, Gynecology and Reproduction. 2020;14(1):34–43. (In Russ.). https://doi.org/10.17749/2313-7347.2020.14.1.34-43.
13. Obimbo M.M., Zhou Y., McMaster M.T. et al. Placental structure in preterm birth among HIV-positive versus HIV-negative women in Kenya. J Acquir Immune Defic Syndr. 2019;80(1):94–102. https://doi.org/10.1097/QAI.0000000000001871.
14. Tusupbekova M.M., Kizatova S.T. Peculiarities of pathomorphology in children with perinatal HIV infection and placental lesions in HIV/AIDS in women. [Osobennosti patomorfologii u detej pri perinatal'noj VICh-infekcii i porazheniya placenty pri VICh/SPIDe u zhenshchin]. Teoreticheskaya i eksperimental'naya medicina. 2017;(4):86–93. (In Russ.).
15. Belotserkovtseva L.D., Kovalenko L.V., Tefnants N.A., Kasparova A.E. Morphofunctional changes in placenta in patients with HIV who transmitted viral infection to their child. [Morfofunkcional'nye izmeneniya v placente u pacientok s VICh pri virusnom porazhenii detej infekciej]. Vestnik Novgorodskogo gosudarstvennogo universiteta. 2018;(6):4–8. (In Russ.).
16. Kolobov A.V. The morphogenesis of the human placenta and its morphofunctional state in the pathology of pregnancy. [Morfogenez placenty cheloveka i ee morfofunkcional'noe sostoyanie pri patologii beremennosti]. Vestnik Sankt-Peterburgskogo universiteta. 2015;11(2):5–18. (In Russ).
17. Kurbanov Sh.M., Rakhmatulloeva D.M., Yuldasheva O.E., Bagdasarova N.Kh. Peculiarities of fetoplacenta in pregnant women with viral hepatitis. [Osobennosti fetoplacentarnogo kompleksa u beremennyh s virusnymi gepatitami]. Vestnik Avicenny. 2011;(2):44–8. (In Russ).
Review
For citation:
Pseush S.Yu., Zozulya L.V., Mikhaleva L.L. The predictive value indicators of first trimester biochemical screening in assessing unfavorable factors of pregnancy course in women with HIV as well as hepatitis B and C. Obstetrics, Gynecology and Reproduction. 2021;15(6):686-694. (In Russ.) https://doi.org/10.17749/2313-7347/ob.gyn.rep.2021.240
Views: 99
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Email this article 
